SIRT3通过去乳酸化H3K18抑制类风湿关节炎成纤维样滑膜细胞活化
该研究探讨组蛋白乳酸化尤其是H3K18la在类风湿关节炎(RA)发病中的作用及SIRT3介导的去乳酸化机制。RA患者滑膜组织中H3K18la显著升高,降低H3K18la可缓解CIA模型症状并减轻TNF-α对FLS的致病效应;RA患者PBMCs中SIRT3下调,SIRT3减少使FLS和巨噬细胞中H3K18la升高并激活FLS。
要点
- RA患者滑膜组织中H3K18la水平显著升高。
- 降低H3K18la可缓解CIA模型症状并减轻TNF-α对FLS的致病效应。
- RA患者PBMCs中SIRT3下调,SIRT3减少使FLS和巨噬细胞H3K18la升高并激活FLS。
核心结论
- SIRT3通过去乳酸化H3K18抑制RA进展,该发现可能为RA的乳酸化靶向治疗开辟新途径。
研究设计与样本
- 采用蛋白质印迹和免疫组化检测RA患者滑膜组织中H3K18la水平,并结合CIA模型与成纤维样滑膜细胞(FLS)探索H3K18la的作用。
- 使用CUT&Tag和RNA测序鉴定H3K18la驱动的通路,并通过si-SIRT3和SIRT3激动剂和厚朴酚在FLS中验证SIRT3功能。
- 检测RA患者外周血单个核细胞(PBMCs)中SIRT3表达,并通过巨噬细胞-FLS共培养实验评估SIRT3敲低的影响。
主要发现
- 乳酸化尤其是H3K18la在RA患者滑膜组织中显著升高。
- 降低H3K18la可缓解CIA模型相关症状并减轻TNF-α对FLS的致病效应,而升高H3K18la则加重TNF-α诱导的病理。
- H3K18la与乳酸共同调控的通路包括趋化因子信号和瞬时受体电位通道的炎症介质。
- SIRT3作为H3K18la的关键调节因子,在RA患者PBMCs中下调;SIRT3减少使FLS和巨噬细胞中H3K18la升高,从而激活FLS。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Metabolic reprogramming and epigenetic modifications are key contributors to the development of RA. Recent studies have identified lactate-dependent histone modifications as a novel epigenetic mechanism linking glycolysis to gene regulation. However, the precise role of histone lactylation in RA pathogenesis remains unclear. We aimed to elucidate the specific mechanism of histone lactylation, particularly H3K18la, in the pathogenesis of RA and to explore the therapeutic potential of the SIRT3-mediated delactylation process. METHODS: H3K18la levels in synovial tissue from RA patients were assessed using western blot and immunohistochemistry. CIA models combined with fibroblast-like synoviocytes (FLS) were used to explore H3K18la effects. CUT&Tag and RNA-sequencing identified pathways driven by H3K18la. SIRT3 function was validated using si-SIRT3 and the SIRT3 agonist honokiol in FLS. SIRT3 expression was assessed in peripheral blood mononuclear cells (PBMCs) from RA patients, and macrophage-FLS co-culture experiments evaluated SIRT3 knockdown effects. RESULTS: Lactylation, particularly H3K18la, was significantly elevated in the synovial tissue of RA patients. Reducing H3K18la alleviated CIA model-associated symptoms and mitigated the pathogenic effects of TNF-α on FLS, whereas increasing H3K18la exacerbated TNF-α-induced pathology. H3K18la and lactate co-regulated pathways included chemokine signalling and the inflammatory mediator of transient receptor potential channels. Furthermore, SIRT3, a key regulator of H3K18la, was downregulated in PBMCs from RA patients. Reduced SIRT3 increased H3K18la in FLS and macrophages, which activated FLS. CONCLUSIONS: SIRT3 suppresses RA progression by delactylating H3K18. These findings may pave the way for novel lactylation-targeted therapies in RA.
引用
- Zheng J, Liu C, Hao J, et al. SIRT3 inhibits fibroblast-like synoviocytes activation in rheumatoid arthritis through delactylation of H3K18. Rheumatology (Oxford). 2025. PMID: 40973046. doi:10.1093/rheumatology/keaf497
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。